Gly-Pro
Natural health product licensed in Canada
- Other names
- Progressive Labs Gly-Resilience, Progressive Labs Gly-Pro
- Licence holder
- Bio Lonreco Inc.
- NPN or DIN-HM
- 80090484
- Status
- Inactive licence
- Licence date
- 6 February 2019
- Revision date
- 6 July 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Galega officinalis Source : Herbe(s) | 75 mg | Not calculated |
| Vanadium Source : Bisglycinato oxo vanadium | 25 mcg | Not calculated |
| Momordica charantia Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 2,250 mg | 225 mg | Not calculated |
| Ecklonia cava Source : Thalle Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 40 mg Potency : 95 % phénoliques | 5 mg | Not calculated |
Non-medicinal ingredients
farine de riz, Monostéarate de glycéryle, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Contribue au sain métabolisme du glucose. Aide au maintien des niveaux normaux de glucose sanguin. Aide à maintenir les capacités du corps à métaboliser les nutriments.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Une hypersensibilité/ allergie peut se manifester. Dans ce cas, cesser l'utilisation.
- Précautions et mises en garde
Si vous souffrez de diabète, consultez un praticien de soins de santé avant d'en faire l'usage. Si des symptômes d'hypoglycémie incluant de l'anxiété, des étourdissements, des tremblements, des sueurs, des nausées ou des maux de tête se manifestent, cesser l'usage. Consulter un professionnel de la santé avant d'utiliser si vous avez des troubles intestinaux, ou des symptômes tels que douleurs abdominales, nausées, vomissements ou fièvre.
- Contre-indications
Ne pas utiliser si vous êtes enceinte ou si vous allaitez.
Source
Official Health Canada record, licence 80090484
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging